Atea Pharmaceuticals

Concentra finds latest acquisition attempt harder to swallow as Atea rejects 'undervalued' offer
Fierce Biotech
Tue, 05/30/23 - 09:22 pm
Concerta Biosciences
M&A
Atea Pharmaceuticals
Concentra rebounds from Jounce buy with a shot at COVID-19-focused Atea
Fierce Biotech
Mon, 05/22/23 - 09:58 pm
Concerta Biosciences
Atea Pharmaceuticals
M&A
COVID-19
Atea dumps dengue drug as 'unevaluable' endpoint causes timelines, forecast costs to spiral
Fierce Biotech
Wed, 03/1/23 - 06:52 pm
Atea Pharmaceuticals
dengue
clinical trials
AT-752
Big Pharma has skirted long Covid, but a pipeline of small biotechs are testing treatments for lingering symptoms
Endpoints
Sun, 03/27/22 - 03:58 pm
COVID-19
Long COVID
GSK
Vir Biotechnology
Humanigen
Pfizer
Roche
Atea Pharmaceuticals
Atea sticks it out with failed COVID-19 antiviral but also raids Merck's store room for hepatitis C drug
Fierce Biotech
Fri, 01/7/22 - 10:47 am
Atea Pharmaceuticals
antivirals
COVID-19
Merck
bemnifosbuvir.
As Merck and Pfizer predict incoming billions from their COVID drugs, Roche culls pandemic ties with Atea
Fierce Biotech
Wed, 11/17/21 - 10:28 am
Roche
Merck
Pfizer
Atea Pharmaceuticals
COVID-19
Atea’s antiviral pill fails to clear Covid-19, forcing a re-think
Stat
Tue, 10/19/21 - 10:48 am
Atea Pharmaceuticals
COVID-19
antivirals
clinical trials
Roche
AT-527
Can This Duo Outperform Merck and Ridgeback Biotherapeutics' COVID Treatment?
Motley Fool
Fri, 10/8/21 - 10:58 am
COVID-19
Merck
Ridgeback Therapeutics
Roche
Atea Pharmaceuticals
AT-527
antivirals
Pfizer's CEO Wants to Go Shopping: 3 Potential Companies on His Radar
Motley Fool
Thu, 08/5/21 - 10:57 am
Pfizer
M&A
Blueprint Medicines
Aurinia Pharmaceuticals
Atea Pharmaceuticals
Scientists work toward an elusive dream: a simple pill to treat Covid-19
Stat
Fri, 04/9/21 - 10:56 am
COVID-19
drug development
Merck
Ridgeback Biotherapeutics
molnupiravir
Pfizer
Atea Pharmaceuticals
Atea, riding interest in COVID-19 drugs, pulls off one of 2020's top biotech IPOs
BioPharma Dive
Fri, 10/30/20 - 10:30 am
Atea Pharmaceuticals
COVID-19
IPOs
small molecule drugs
Roche joins the COVID-19 antiviral drug race, betting $350M on a startup
BioPharma Dive
Thu, 10/22/20 - 10:51 am
Roche
antivirals
Atea Pharmaceuticals
COVID-19
AT-527
Atea raises $215M to support midphase COVID-19 antiviral trial
Fierce Biotech
Wed, 05/20/20 - 10:30 am
Atea Pharmaceuticals
clinical trials
COVID-19
antivirals
AT-527